Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity - Additional Information (Details1)

v3.24.1
Stockholders' Equity - Additional Information (Details1) - USD ($)
 12 Months Ended
Jan. 01, 2024
May 25, 2023
Dec. 31, 2023
Dec. 31, 2022
Aug. 01, 2022
Subsidiary or Equity Method Investee [Line Items]          
Stock options outstanding     7,750,152 6,545,628  
Fair value assumptions, contractual term     7 years    
Percentage of shares granted     10.00%    
Exercise price percentage     110.00%    
Common stock, par value     $ 0.0001 $ 0.0001  
Stock Options          
Subsidiary or Equity Method Investee [Line Items]          
Weighted-average grant date fair value     $ 2.55 3.75  
Unrecognized compensation     $ 1,790,683    
Unrecognized compensation expense, recognized period     2 years 11 months 23 days    
January 1 to January 26, 2022          
Subsidiary or Equity Method Investee [Line Items]          
Common stock, par value       $ 8.87  
January 27 to May 31, 2022          
Subsidiary or Equity Method Investee [Line Items]          
Sale of common stock, price per share     $ 9    
June 1, 2022 to August 1, 2022          
Subsidiary or Equity Method Investee [Line Items]          
Sale of common stock, price per share     $ 5    
Maximum          
Subsidiary or Equity Method Investee [Line Items]          
Fair value assumptions, contractual term     10 years    
Maximum | Stock Options          
Subsidiary or Equity Method Investee [Line Items]          
Fair value assumptions, contractual term     6 years 3 months 6 years 3 months  
2018 Stock Option Plan          
Subsidiary or Equity Method Investee [Line Items]          
Stock options outstanding     1,924,500    
Amended and Restated 2020 Equity Incentive Plan          
Subsidiary or Equity Method Investee [Line Items]          
Stock options outstanding     3,852,187    
Common stock reserved for issuance     0    
2021 Equity Incentive Plan          
Subsidiary or Equity Method Investee [Line Items]          
Stock options outstanding     1,973,465    
Common stock reserved for issuance     2,023,132 1,956,993 1,909,518
Percentage of increase in stock outstanding fully diluted   10.00%      
2021 Equity Incentive Plan | Subsequent Event          
Subsidiary or Equity Method Investee [Line Items]          
Increase common stock capital shares reserved for future issuance 2,838,668